Exposure-response relationship of ramucirumab in RANGE, a randomized phase III trial in advanced urothelial carcinoma refractory to platinum therapy

  1. de Wit, R.
  2. Powles, T.
  3. Castellano, D.
  4. Necchi, A.
  5. Lee, J.-L.
  6. van der Heijden, M.S.
  7. Matsubara, N.
  8. Bamias, A.
  9. Fléchon, A.
  10. Sternberg, C.N.
  11. Drakaki, A.
  12. Yu, E.Y.
  13. Zimmermann, A.H.
  14. Long, A.
  15. Walgren, R.A.
  16. Gao, L.
  17. Bell-McGuinn, K.M.
  18. Petrylak, D.P.
Journal:
British Journal of Clinical Pharmacology

ISSN: 1365-2125 0306-5251

Year of publication: 2022

Volume: 88

Issue: 7

Pages: 3182-3192

Type: Article

DOI: 10.1111/BCP.15233 GOOGLE SCHOLAR lock_openOpen access editor